Search

Your search keyword '"Catchpole, Andrew"' showing total 461 results

Search Constraints

Start Over You searched for: Author "Catchpole, Andrew" Remove constraint Author: "Catchpole, Andrew"
461 results on '"Catchpole, Andrew"'

Search Results

1. Human SARS-CoV-2 challenge uncovers local and systemic response dynamics

2. Author Correction: Human SARS-CoV-2 challenge uncovers local and systemic response dynamics

3. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

4. Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study

7. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults

9. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

10. Third human challenge trial conference, Oxford, United Kingdom, February 6–7, 2020, a meeting report

11. Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults.

12. SARS-CoV-2 human challenge reveals single-gene blood transcriptional biomarkers that discriminate early and late phases of acute respiratory viral infections

14. Human SARS-CoV-2 challenge resolves local and systemic response dynamics

18. Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study

19. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge

20. Viral Emissions into the Air and Environment after SARS-CoV-2 Human Challenge: A Phase 1, Open Label, First-in-Human Study

21. Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis

22. 998. Forward and Reverse Translational Approaches to Predict Efficacy of the Neutralizing Respiratory Syncytial Virus (RSV) Antibody MK-1654

25. Malbec and beyond: to help assess Argentina's appeal across leading restaurants and food-led pubs, Harpers teamed up with a number of producers to trial their wines in the on-trade

30. Third human challenge trial conference, Oxford, United Kingdom, February 6–7, 2020, a meeting report

32. MOESM1 of The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development process

38. The Cape sets its sights on the top spot: as South Africa prepares for the first Cape Wine in four years, Andrew Catchpole asks how a shift in the UK market has affected producers and how top-end wines have become a renewed focus

40. A Tool for Investigating Asthma and COPD Exacerbations: A Newly Manufactured and Well Characterised GMP Wild-Type Human Rhinovirus for Use in the Human Viral Challenge Model

41. Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

42. Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

43. SOUTH AFRICA.

44. PORTUGAL.

46. ALL CHANGE.

48. Squaring up to sustainability.

Catalog

Books, media, physical & digital resources